Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Trial of Cisplatin With or Without Veliparib in Metastatic TNBC and/or BRCA Mutation-Associated Breast Cancer
NCT02595905Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Sep 2016
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of veliparib in breast cancer, sponsored by National Cancer Institute. Started Sep 2016; status: completed.
02
Drugs
veliparib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02595905.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02595905.